Primary dysmenorrhoea (Usre tams ibtidaee) is the most common gynecological disorder in menstruating women. It is a common menstrual cramps with high prevalence rate; responsible for the highest incidence of absenteeism resulting in loss of working hours. In addition both work & school performances are found to be poor in women on their days with dysmenorrhoea. Thus, proper treatment is essential to over the hardship, so, in present study the objective is to evaluate the efficacy and safety of hullba and hijamat bila shrut in the management of dysmenorrhoea. A randomized, standard controlled clinical trial was conducted in OPD of DUMCH-RC from August 2014 to February 2016. A total of 60 patients diagnosed with primary dysmenorrhoea aged between 12-30 years were assigned randomly to the interventions. The test group A (n=20) received 3gm of Hulba (Trigonella foenum graecum) twice daily from day 1 to day 3 of menstrual cycle. The test group B (n=20) received same dose of Hulba with dry cupping (hijamat bila shurt). These interventions were given for three consecutive cycles. The results were analyzed and compared statistically by using Analysis of variance (ANOVA), Chi-square or Fisher Exact test to find the significance of study parameters. The groups showed similarity in terms of baseline characteristics and biochemical parameters (P>0.05). The inter group comparison showed that group A was equally effective as group B and C (P>0.05), whereas group B was more- effective than group C (P=0.02) in reducing pain intensity. The associated symptoms were also improved in all groups. No adverse drug effects were observed. Hulba was as effective as mefanamic acid, whereas Hulba with dry cupping was more effective than mefanamic acid in reducing pain intensity and discomfort. The test drug (Hulba) and dry Cupping were found to be more effective in the management of primary dysmenorrhoea. Keywords: Primary.dysmenorrhoea; Usre Tams Ibtidaee; Hulba; Hijamat bila shurt; Visual An